Neurogene Inc. Share Price
NASDAQ: NGNE$0.00
+0.00 (0.00%) Neurogene Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Neurogene Inc. Share Price Chart
$0.00$0.00
L
H
Neurogene Inc. Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $-4.24 | Revenue (TTM) N/A | Return On Equity (TTM) -34.11% |
Profit Margin N/A | Debt to Equity 0.06 | Quarterly Earnings Growth YoY -13.31% |
Neurogene Inc. Quarterly Profit & Loss
All figures in USD
Neurogene Inc. Annual Profit & Loss
All figures in USD
About Neurogene Inc.
Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreements with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.
Neurogene Inc. Historical Returns
| Month | Open | Close | Change % |
|---|
NGNE Share Price FAQs
What is Neurogene Inc. share price today?
Neurogene Inc. share price today is $0.00 as on August 9, 2026 at 7:17 pm IST.
What is the 52 week high and 52 week low of Neurogene Inc. stock?
52 week high/low data for Neurogene Inc. is currently unavailable.
What is NGNE's net income for the last quarter?
NGNE's net income for the last quarter is -0.02B USD.
Can I buy NGNE shares in India?
Yes. You can buy NGNE in India by opening an international trading account.